Erectile dysfunction in the cardiovascular patient.

Erectile dysfunction is common in the patient with cardiovascular disease. It is an important component of the quality of life and it also confers an independent risk for future cardiovascular events. The usual 3-year time period between the onset of erectile dysfunction symptoms and a cardiovascular event offers an opportunity for risk mitigation. Thus, sexual function should be incorporated into cardiovascular disease risk assessment for all men. A comprehensive approach to cardiovascular risk reduction (comprising of both lifestyle changes and pharmacological treatment) improves overall vascular health, including sexual function. Proper sexual counselling improves the quality of life and increases adherence to medication. This review explores the critical connection between erectile dysfunction and cardiovascular disease and evaluates how this relationship may influence clinical practice. Algorithms for the management of patient with erectile dysfunction according to the risk for sexual activity and future cardiovascular events are proposed.

[1]  C. Vlachopoulos,et al.  Prediction of Cardiovascular Events and All-Cause Mortality With Erectile Dysfunction: A Systematic Review and Meta-Analysis of Cohort Studies , 2012, Circulation. Cardiovascular quality and outcomes.

[2]  M. Maggi,et al.  Testosterone deficiency in men: systematic review and standard operating procedures for diagnosis and treatment. , 2013, The journal of sexual medicine.

[3]  D. Goff,et al.  Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. , 2012, JAMA.

[4]  R. Kloner,et al.  The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. , 2012, Mayo Clinic proceedings.

[5]  Shah Ebrahim,et al.  European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.

[6]  R. Kloner,et al.  Prognostic utility of erectile dysfunction for cardiovascular disease in younger men and those with diabetes. , 2012, American heart journal.

[7]  H. Krumholz,et al.  Patterns and loss of sexual activity in the year following hospitalization for acute myocardial infarction (a United States National Multisite Observational Study). , 2012, The American journal of cardiology.

[8]  A. Manolis,et al.  Antihypertensive Treatment and Sexual Dysfunction , 2012, Current Hypertension Reports.

[9]  I. Goldstein,et al.  Cardiometabolic risk and female sexual health: the Princeton III summary. , 2012, The journal of sexual medicine.

[10]  J. Conti,et al.  Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association. , 2012, Circulation.

[11]  G. Rosano,et al.  Exogenous testosterone, cardiovascular events, and cardiovascular risk factors in elderly men: a review of trial data. , 2012, The journal of sexual medicine.

[12]  M. Murad,et al.  The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis. , 2011, Archives of internal medicine.

[13]  G. Forti,et al.  Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study. , 2011, European journal of endocrinology.

[14]  E. Barrett-Connor,et al.  High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden. , 2011, Journal of the American College of Cardiology.

[15]  J. Paulus,et al.  Association of episodic physical and sexual activity with triggering of acute cardiac events: systematic review and meta-analysis. , 2011, JAMA.

[16]  M. Böhm,et al.  Cardiovascular risk, drugs and erectile function – a systematic analysis , 2011, International journal of clinical practice.

[17]  P. Anyfanti,et al.  Hypertension and sexual dysfunction: time to act. , 2011, Journal of hypertension.

[18]  J. Kaufman,et al.  Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis , 2010, Heart.

[19]  E. Schwarz,et al.  Erectile Dysfunction as a Complication of Heart Failure , 2010, Current heart failure reports.

[20]  A. Jette,et al.  Adverse events associated with testosterone administration. , 2010, The New England journal of medicine.

[21]  H. Völzke,et al.  Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79. , 2010, European heart journal.

[22]  F. Montorsi,et al.  Erectile dysfunction and coronary artery disease prediction: evidence‐based guidance and consensus , 2010, International journal of clinical practice.

[23]  G. Jackson.  Testosterone deficiency syndrome (TDS) and the heart. , 2010, European heart journal.

[24]  C. Vlachopoulos,et al.  Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness , 2011 .

[25]  S. Yusuf,et al.  Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or Both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONT , 2010, Circulation.

[26]  T. Travison,et al.  Does erectile dysfunction contribute to cardiovascular disease risk prediction beyond the Framingham risk score? , 2010, Journal of the American College of Cardiology.

[27]  F. Montorsi,et al.  Safety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety database , 2009, International journal of clinical practice.

[28]  V. Jinga,et al.  Diagnosis and treatment of erectile dysfunction– a practical update , 2009, Journal of medicine and life.

[29]  A. Dominiczak,et al.  Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. , 2009, Journal of hypertension.

[30]  F. Veglia,et al.  Erectile dysfunction in heart failure: correlation with severity, exercise performance, comorbidities, and heart failure treatment. , 2009, The journal of sexual medicine.

[31]  C. Vlachopoulos,et al.  Cardiovascular effects of phosphodiesterase type 5 inhibitors. , 2009, The journal of sexual medicine.

[32]  Giuseppe Mancia,et al.  Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document , 2009, Blood pressure.

[33]  C. Vlachopoulos,et al.  The triad: erectile dysfunction--endothelial dysfunction--cardiovascular disease. , 2008, Current pharmaceutical design.

[34]  C. Vlachopoulos,et al.  Arterial function and intima-media thickness in hypertensive patients with erectile dysfunction , 2008, Journal of hypertension.

[35]  G. Jackson,et al.  Erectile dysfunction and silent coronary artery disease: abnormal computed tomography coronary angiogram in the presence of normal exercise ECGs , 2008, International journal of clinical practice.

[36]  C. Gazzaruso,et al.  Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors. , 2008, Journal of the American College of Cardiology.

[37]  A. Schoenenberger,et al.  Effects of anti-ischaemic drug therapy in silent myocardial ischaemia type I: the Swiss Interventional Study on Silent Ischaemia type I (SWISSI I): a randomized, controlled pilot study. , 2007, European heart journal.

[38]  C. Vlachopoulos,et al.  Unfavourable endothelial and inflammatory state in erectile dysfunction patients with or without coronary artery disease. , 2006, European heart journal.

[39]  G. Jackson.  Erectile dysfunction: a marker of silent coronary artery disease. , 2006, European heart journal.

[40]  F. Montorsi,et al.  Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial. , 2006, European heart journal.

[41]  F. Montorsi,et al.  Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient. , 2006, European urology.

[42]  L. Kiemeney,et al.  Cardiovascular risk among men seeking help for erectile dysfunction. , 2006, Annals of epidemiology.

[43]  G. Jackson,et al.  Erectile dysfunction and statin treatment in high cardiovascular risk patients , 2006, International journal of clinical practice.

[44]  I. Thompson,et al.  Erectile dysfunction and subsequent cardiovascular disease. , 2005, JAMA.

[45]  C. Vlachopoulos,et al.  Prevalence of asymptomatic coronary artery disease in men with vasculogenic erectile dysfunction: a prospective angiographic study. , 2005, European urology.

[46]  J. Cappelleri,et al.  The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experience , 2005, International Journal of Impotence Research.

[47]  G. Rosano,et al.  Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by placebo. , 2003, European heart journal.

[48]  F. Montorsi,et al.  Is erectile dysfunction the "tip of the iceberg" of a systemic vascular disorder? , 2003, European urology.

[49]  F. Montorsi,et al.  Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. , 2003, European urology.

[50]  G. Jackson,et al.  Relation of erectile dysfunction to angiographic coronary artery disease. , 2003, The American journal of cardiology.

[51]  A. Araujo,et al.  Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. , 2000, The Journal of urology.

[52]  E. Smith.  Erectile dysfunction in the cardiovascular patient. , 1999, The Canadian journal of cardiology.